Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical nitric oxide for cutaneous leishmaniasis
IRCT138710191535N1Phase 3Completed
- Sponsor
- ُShiraz University of Medical Sciences
- Start
- Sep 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in cutaneous leishmaniasis (CL), sponsored by ُShiraz University of Medical Sciences. Started Sep 2007; status: completed.
02
Drugs
nitric oxide
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT138710191535N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138710191535N1.